THE CHANGES OF NITRIC OXIDE SERUM LEVELS IN PATIENTS WITH END-STAGE RENAL DISEASE

Authors

  • Sarah F.Hussein Department of Chemistry, College of Science, Al-Nahrain University, Jadrya Baghdad,Iraq.
  • Alaa Hussein J. Al-qaisi Department of Chemistry, College of Science, Al-Nahrain University, Jadrya Baghdad,Iraq.
  • TS Morad Department of Chemistry, College of Science, Al-Nahrain University, Jadrya Baghdad,Iraq.

Keywords:

Chronic, Failure, oxide, phosphorus

Abstract

Chronic Renal Failure (CRF) is a term used to describe an irreversible decline in renal function that often occurs over a number of years. In many situations, an initial insult to the kidney function leads to additional nephron loss and the requirement for dialysis or kidney transplantation End stage renal disease (ESRD) is the term used to describe this ailment. Patients with chronic kidney disease (CKD) are at an increased risk of cardiovascular (CVD) morbidity and mortality, mainly due to atherosclerosis. Decreased production or reduced bioavailability of nitric oxide (NO) can result in endothelial dysfunction (ED). Multiple mechanisms are known to cause a state of NO deficiency in patients with CKD. this study compares the levels of (NO), and its ratios, in ESRD patients and healthy controls

Downloads

Published

2022-09-30

How to Cite

Sarah F.Hussein, Alaa Hussein J. Al-qaisi, & TS Morad. (2022). THE CHANGES OF NITRIC OXIDE SERUM LEVELS IN PATIENTS WITH END-STAGE RENAL DISEASE. World Bulletin of Public Health, 14, 96-99. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/1418

Issue

Section

Articles